About this Journal Submit a Manuscript Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2013 (2013), Article ID 695925, 14 pages
http://dx.doi.org/10.1155/2013/695925
Review Article

Depression and Cardiac Disease: Epidemiology, Mechanisms, and Diagnosis

1Harvard Medical School, Boston, MA 02114, USA
2Department of Psychiatry, Massachusetts General Hospital, Blake 11, 55 Fruit Street, Boston, MA 02114, USA
3Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA

Received 29 January 2013; Accepted 18 March 2013

Academic Editor: Kenji Hashimoto

Copyright © 2013 Jeff C. Huffman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Mavrides and C. Nemeroff, “Treatment of depression in cardiovascular disease,” Depression and Anxiety, 2013. View at Publisher · View at Google Scholar
  2. C. M. Celano and J. C. Huffman, “Depression and cardiac disease: a review,” Cardiology in Review, vol. 19, no. 3, pp. 130–142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. M. Carney and K. E. Freedland, “Depression in patients with coronary heart disease,” The American Journal of Medicine, vol. 121, no. 11, supplement 1, pp. S20–S27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Lespérance, N. Frasure-Smith, M. Juneau, and P. Théroux, “Depression and 1-year prognosis in unstable angina,” Archives of Internal Medicine, vol. 160, no. 9, pp. 1354–1360, 2000. View at Scopus
  5. S. J. Schleifer, M. M. Macari-Hinson, D. A. Coyle et al., “The nature and course of depression following myocardial infarction,” Archives of Internal Medicine, vol. 149, no. 8, pp. 1785–1789, 1989. View at Scopus
  6. B. D. Thombs, P. de Jonge, J. C. Coyne et al., “Depression screening and patient outcomes in cardiovascular care: a systematic review,” The Journal of the American Medical Association, vol. 300, no. 18, pp. 2161–2171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. B. D. Thombs, E. B. Bass, D. E. Ford et al., “Prevalence of depression in survivors of acute myocardial infarction: review of the evidence,” Journal of General Internal Medicine, vol. 21, no. 1, pp. 30–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Kessler, P. Berglund, O. Demler et al., “The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R),” The Journal of the American Medical Association, vol. 289, no. 23, pp. 3095–3105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Hedayati, H. B. Bosworth, M. Kuchibhatla, P. L. Kimmel, and L. A. Szczech, “The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients,” Kidney International, vol. 69, no. 9, pp. 1662–1668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Snyderman and D. Wynn, “Depression in cancer patients,” Primary Care—Clinics in Office Practice, vol. 36, no. 4, pp. 703–719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Magyar-Russell, B. D. Thombs, J. X. Cai et al., “The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review,” Journal of Psychosomatic Research, vol. 71, no. 4, pp. 223–231, 2011. View at Publisher · View at Google Scholar
  12. T. Rutledge, V. A. Reis, S. E. Linke, B. H. Greenberg, and P. J. Mills, “Depression in heart failure. A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1527–1537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. McCabe, “Psychological distress in patients diagnosed with atrial fibrillation: the state of the science,” Journal of Cardiovascular Nursing, vol. 25, no. 1, pp. 40–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Tully and R. A. Baker, “Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review,” Journal of Geriatric Cardiology, vol. 9, no. 2, pp. 197–208, 2012. View at Publisher · View at Google Scholar
  15. A. H. Glassman, J. T. Bigger, M. Gaffney, P. A. Shapiro, and J. R. Swenson, “Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit,” Archives of General Psychiatry, vol. 63, no. 3, pp. 283–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Lespérance, N. Frasure-Smith, D. Koszycki et al., “Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial,” The Journal of the American Medical Association, vol. 297, no. 4, pp. 367–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Huffman, C. A. Mastromauro, G. L. Sowden, C. Wittmann, R. Rodman, and J. L. Januzzi, “A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes,” Psychosomatics, vol. 52, no. 1, pp. 26–33, 2011. View at Scopus
  18. M. Hance, R. M. Carney, K. E. Freedland, and J. Skala, “Depression in patients with coronary heart disease: a 12-month follow-up,” General Hospital Psychiatry, vol. 18, no. 1, pp. 61–65, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Martens, O. R. F. Smith, J. Winter, J. Denollet, and S. S. Pedersen, “Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction,” Psychological Medicine, vol. 38, no. 2, pp. 257–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. I. Kaptein, P. de Jonge, R. H. S. van den Brink, and J. Korf, “Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis,” Psychosomatic Medicine, vol. 68, no. 5, pp. 662–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. G. Koenig, “Depression outcome in inpatients with congestive heart failure,” Archives of Internal Medicine, vol. 166, no. 9, pp. 991–996, 2006. View at Scopus
  22. T. Suzuki, T. Shiga, K. Kuwahara et al., “Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study,” Pacing and Clinical Electrophysiology, vol. 33, no. 12, pp. 1455–1461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The patient health questionnaire-2: validity of a two-item depression screener,” Medical Care, vol. 41, no. 11, pp. 1284–1292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The PHQ-9: validity of a brief depression severity measure,” Journal of General Internal Medicine, vol. 16, no. 9, pp. 606–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Shankman, J. Nadelson, S. K. McGowan, A. A. Sovari, and M. I. Vidovich, “The predictive power of depression screening procedures for veterans with coronary artery disease,” Journal of Vascular Health and Risk Management, vol. 8, pp. 233–238, 2012. View at Publisher · View at Google Scholar
  26. M. A. Caro, G. L. Sowden, C. A. Mastromauro et al., “Risk factors for positive depression screens in hospitalized cardiac patients,” Journal of Cardiology, vol. 60, no. 1, pp. 72–77, 2012. View at Publisher · View at Google Scholar
  27. S. Mallik, J. A. Spertus, K. J. Reid et al., “Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women,” Archives of Internal Medicine, vol. 166, no. 8, pp. 876–883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. M. H. Strik, R. Lousberg, E. C. Cheriex, and A. Honig, “One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome,” Journal of Psychosomatic Research, vol. 56, no. 1, pp. 59–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Shanmugasegaram, K. L. Russell, A. H. Kovacs, D. E. Stewart, and S. L. Grace, “Gender and sex differences in prevalence of major depression in coronary artery disease patients: a meta-analysis,” Maturitas, vol. 73, no. 4, pp. 305–311, 2012. View at Publisher · View at Google Scholar
  30. A. M. Busch, B. Borrelli, and A. M. Leventhal, “The relationship between smoking and depression post-acute coronary syndrome,” Current Cardiovascular Risk Reports, vol. 5, no. 6, pp. 510–518, 2012.
  31. T. A. Spijkerman, R. H. S. van den Brink, J. H. C. Jansen, H. J. G. M. Crijns, and J. Ormel, “Who is at risk of post-MI depressive symptoms?” Journal of Psychosomatic Research, vol. 58, no. 5, pp. 425–432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Frazier, E. Yu, J. Sanner et al., “Gender differences in self-reported symptoms of depression among patients with acute coronary syndrome,” Nursing Research and Practice, vol. 2012, Article ID 109251, 5 pages, 2012. View at Publisher · View at Google Scholar
  33. F. M. Pena, F. Modenesi Rde, M. C. Piraciaba et al., “Prevalence and variables predictive of depressive symptoms in patients hospitalized for heart failure,” Cardiology Journal, vol. 18, no. 1, pp. 18–25, 2011.
  34. M. K. Sin, “Personal characteristics predictive of depressive symptoms in Hispanics with heart failure,” Issues in Mental Health Nursing, vol. 33, no. 8, pp. 522–527, 2012. View at Publisher · View at Google Scholar
  35. N. Lossnitzer, W. Herzog, S. Stork et al., “Incidence rates and predictors of major and minor depression in patients with heart failure,” International Journal of Cardiology, 2012. View at Publisher · View at Google Scholar
  36. A. Dunkel, F. Kendel, E. Lehmkuhl et al., “Predictors of preoperative depressive risk in patients undergoing coronary artery bypass graft surgery,” Clinical Research in Cardiology, vol. 98, no. 10, pp. 643–650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. L. H. McKenzie, J. Simpson, and M. Stewart, “A systematic review of pre-operative predictors of post-operative depression and anxiety in individuals who have undergone coronary artery bypass graft surgery,” Psychology, Health and Medicine, vol. 15, no. 1, pp. 74–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Freedenberg, S. A. Thomas, and E. Friedmann, “Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review,” Heart Failure Clinics, vol. 7, no. 1, pp. 59–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. L. V. Doering, D. K. Moser, B. Riegel et al., “Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease,” International Journal of Cardiology, vol. 145, no. 2, pp. 188–192, 2010. View at Publisher · View at Google Scholar
  40. J. Denollet, J. J. Strik, R. Lousberg, and A. Honig, “Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression,” Psychotherapy and Psychosomatics, vol. 75, no. 6, pp. 346–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Frasure-Smith and F. Lespérance, “Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease,” Archives of General Psychiatry, vol. 65, no. 1, pp. 62–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. de Schutter, C. J. Lavie, and R. V. Milani, “Relative importance of comorbid psychological symptoms in patients with depressive symptoms following phase II cardiac rehabilitation,” Postgraduate Medicine, vol. 123, no. 6, pp. 72–78, 2011. View at Publisher · View at Google Scholar
  43. B. Bankier, J. L. Januzzi, and A. B. Littman, “The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease,” Psychosomatic Medicine, vol. 66, no. 5, pp. 645–650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. E. J. Martens, P. de Jonge, B. Na, B. E. Cohen, H. Lett, and M. A. Whooley, “Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the heart and soul study,” Archives of General Psychiatry, vol. 67, no. 7, pp. 750–758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Parker, M. Hyett, D. Hadzi-Pavlovic, H. Brotchie, and W. Walsh, “GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome,” Psychiatry Research, vol. 188, no. 3, pp. 383–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. T. K. Dao, D. Chu, J. Springer et al., “Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 3, pp. 606–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. K. H. Ladwig, J. Baumert, B. Marten-Mittag, C. Kolb, B. Zrenner, and C. Schmitt, “Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study,” Archives of General Psychiatry, vol. 65, no. 11, pp. 1324–1330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. von Känel, J. Baumert, C. Kolb, E. Y. N. Cho, and K. H. Ladwig, “Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator,” Journal of Affective Disorders, vol. 131, no. 1-3, pp. 344–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. S. F. Sears, J. D. Hauf, K. Kirian, G. Hazelton, and J. B. Conti, “Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know,” Circulation: Arrhythmia and Electrophysiology, vol. 4, no. 2, pp. 242–250, 2011. View at Publisher · View at Google Scholar
  50. A. C. Phillips, G. D. Batty, C. R. Gale et al., “Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study,” Psychosomatic Medicine, vol. 71, no. 4, pp. 395–403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Roest, M. Zuidersma, and P. de Jonge, “Myocardial infarction and generalised anxiety disorder: 10-year follow-up,” The British Journal of Psychiatry, vol. 200, no. 4, pp. 324–329, 2012. View at Publisher · View at Google Scholar
  52. K. Kroenke, R. L. Spitzer, J. B. W. Williams, and B. Löwe, “An ultra-brief screening scale for anxiety and depression: the PHQ-4,” Psychosomatics, vol. 50, no. 6, pp. 613–621, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. R. L. Spitzer, K. Kroenke, J. B. W. Williams, and B. Löwe, “A brief measure for assessing generalized anxiety disorder: the GAD-7,” Archives of Internal Medicine, vol. 166, no. 10, pp. 1092–1097, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Pizzi, L. Manzoli, S. Mancini, G. Bedetti, F. Fontana, and G. M. Costa, “Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors,” Atherosclerosis, vol. 212, no. 1, pp. 292–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. D. E. Ford, L. A. Mead, P. P. Chang, L. Cooper-Patrick, N. Y. Wang, and M. J. Klag, “Depression is a risk factor for coronary artery disease in men: the precursors study,” Archives of Internal Medicine, vol. 158, no. 13, pp. 1422–1426, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. L. R. Wulsin and B. M. Singal, “Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review,” Psychosomatic Medicine, vol. 65, no. 2, pp. 201–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. R. M. Carney, M. W. Rich, K. E. Freedland et al., “Major depressive disorder predicts cardiac events in patients with coronary artery disease,” Psychosomatic Medicine, vol. 50, no. 6, pp. 627–633, 1988. View at Scopus
  58. W. J. Kop, P. K. Stein, R. P. Tracy, J. I. Barzilay, R. Schulz, and J. S. Gottdiener, “Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression,” Psychosomatic Medicine, vol. 72, no. 7, pp. 626–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. K. van der Kooy, H. van Hout, H. Marwijk, H. Marten, C. Stehouwer, and A. Beekman, “Depression and the risk for cardiovascular diseases: systematic review and meta analysis,” International Journal of Geriatric Psychiatry, vol. 22, no. 7, pp. 613–626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. J. P. van Melle, P. de Jonge, T. A. Spijkerman et al., “Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis,” Psychosomatic Medicine, vol. 66, no. 6, pp. 814–822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Frasure-Smith, F. Lesperance, and M. Talajic, “Depression and 18-month prognosis after myocardial infarction,” Circulation, vol. 91, no. 4, pp. 999–1005, 1995. View at Scopus
  62. W. Whang, L. D. Kubzansky, I. Kawachi et al., “Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the nurses' health study,” Journal of the American College of Cardiology, vol. 53, no. 11, pp. 950–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Frasure-Smith, F. Lesperance, and M. Talajic, “Depression following myocardial infarction: impact on 6-month survival,” The Journal of the American Medical Association, vol. 270, no. 15, pp. 1819–1825, 1993. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Barth, M. Schumacher, and C. Herrmann-Lingen, “Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis,” Psychosomatic Medicine, vol. 66, no. 6, pp. 802–813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Myers, Y. Gerber, Y. Benyamini, U. Goldbourt, and Y. Drory, “Post-myocardial infarction depression: increased hospital admissions and reduced adoption of secondary prevention measures—a longitudinal study,” Journal of Psychosomatic Research, vol. 72, no. 1, pp. 5–10, 2012. View at Publisher · View at Google Scholar
  66. R. C. Ziegelstein, J. A. Fauerbach, S. S. Stevens, J. Romanelli, D. P. Richter, and D. E. Bush, “Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction,” Archives of Internal Medicine, vol. 160, no. 12, pp. 1818–1823, 2000. View at Scopus
  67. P. A. Kurdyak, W. H. Gnam, P. Goering, A. Chong, and D. A. Alter, “The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study,” BMC Health Services Research, vol. 8, article 200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. R. L. Reese, K. E. Freedland, B. C. Steinmeyer, M. W. Rich, J. W. Rackley, and R. M. Carney, “Depression and rehospitalization following acute myocardial infarction,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 6, pp. 626–633, 2011. View at Publisher · View at Google Scholar
  69. Y. W. Leung, D. B. Flora, S. Gravely, J. Irvine, R. M. Carney, and S. L. Grace, “The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis,” Psychosomatic Medicine, vol. 74, no. 8, pp. 786–801, 2012. View at Publisher · View at Google Scholar
  70. K. E. Freedland, R. M. Carney, and M. W. Rich, “Effect of depression on prognosis in heart failure,” Heart Failure Clinics, vol. 7, no. 1, pp. 11–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. H. W. Lange and C. Herrmann-Lingen, “Depressive symptoms predict recurrence of atrial fibrillation after cardioversion,” Journal of Psychosomatic Research, vol. 63, no. 5, pp. 509–513, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. N. Frasure-Smith, F. Lespérance, M. Habra et al., “Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure,” Circulation, vol. 120, no. 2, pp. 134–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Beresnevait, R. Benetis, G. J. Taylor, K. Jurnien, Š. Kinduris, and V. Barauskien, “Depression predicts perioperative outcomes following coronary artery bypass graft surgery,” Scandinavian Cardiovascular Journal, vol. 44, no. 5, pp. 289–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. N. E. Morone, D. K. Weiner, B. H. Belnap et al., “The impact of pain and depression on recovery after coronary artery bypass grafting,” Psychosomatic Medicine, vol. 72, no. 7, pp. 620–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. M. M. Burg, M. C. Benedetto, R. Rosenberg, and R. Soufer, “Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery,” Psychosomatic Medicine, vol. 65, no. 1, pp. 111–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. T. M. Goyal, E. L. Idler, T. J. Krause, and R. J. Contrada, “Quality of life following cardiac surgery: impact of the severity and course of depressive symptoms,” Psychosomatic Medicine, vol. 67, no. 5, pp. 759–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. G. A. Wellenius, K. J. Mukamal, A. Kulshreshtha, S. Asonganyi, and M. A. Mittleman, “Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts,” Circulation, vol. 117, no. 18, pp. 2313–2319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. M. M. Burg, M. C. Benedetto, and R. Soufer, “Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men,” Psychosomatic Medicine, vol. 65, no. 4, pp. 508–510, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. J. A. Blumenthal, H. S. Lett, M. A. Babyak et al., “Depression as a risk factor for mortality after coronary artery bypass surgery,” The Lancet, vol. 362, no. 9384, pp. 604–609, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. K. C. van den Broek, F. B. Tekle, M. Habibovic, M. Alings, P. H. van der Voort, and J. Denollet, “Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator,” International Journal of Cardiology, 2011. View at Publisher · View at Google Scholar
  81. P. de Jonge, A. Honig, J. P. van Melle et al., “Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events,” The American Journal of Psychiatry, vol. 164, no. 9, pp. 1371–1378, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. R. M. Carney, J. A. Blumenthal, K. E. Freedland et al., “Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study,” Psychosomatic Medicine, vol. 66, no. 4, pp. 466–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. A. M. Roest, E. J. Martens, J. Denollet, and P. de Jonge, “Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis,” Psychosomatic Medicine, vol. 72, no. 6, pp. 563–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. R. H. Howland, M. G. Wilson, S. G. Kornstein et al., “Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression,” Annals of Clinical Psychiatry, vol. 20, no. 4, pp. 209–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. A. J. Rush, S. R. Wisniewski, D. Warden et al., “Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features,” Archives of General Psychiatry, vol. 65, no. 8, pp. 870–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. C. M. Celano, C. A. Mastromauro, E. C. Lenihan, J. L. Januzzi, B. L. Rollman, and J. C. Huffman, “Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness,” Psychosomatic Medicine, vol. 74, no. 1, pp. 93–99, 2012. View at Publisher · View at Google Scholar
  87. K. W. Davidson, M. M. Burg, I. M. Kronish et al., “Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome,” Archives of General Psychiatry, vol. 67, no. 5, pp. 480–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Doyle, R. Conroy, and H. McGee, “Differential predictive value of depressive versus anxiety symptoms in the prediction of 8-year mortality after acute coronary syndrome,” Psychosomatic Medicine, vol. 74, no. 7, pp. 711–716, 2012. View at Publisher · View at Google Scholar
  89. N. L. Damen, A. J. Pelle, E. Boersma, P. W. Serruys, R. T. van Domburg, and S. S. Pedersen, “Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry,” European Journal of Preventive Cardiology, vol. 20, no. 1, pp. 127–134, 2013. View at Publisher · View at Google Scholar
  90. J. C. Coyne and J. N. de Voogd, “Are we witnessing the decline effect in the type D personality literature? What can be learned?” Journal of Psychosomatic Research, vol. 73, no. 6, pp. 401–407, 2012. View at Publisher · View at Google Scholar
  91. C. F. Moyer, D. Sajuthi, H. Tulli, and J. K. Williams, “Synthesis of IL-1 α and IL-1 β by arterial cells in atherosclerosis,” The American Journal of Pathology, vol. 138, no. 4, pp. 951–960, 1991.
  92. R. Ross, “Atherosclerosis–an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar
  93. D. Hasper, M. Hummel, F. X. Kleber, I. Reindl, and H. D. Volk, “Systemic inflammation in patients with heart failure,” European Heart Journal, vol. 19, no. 5, pp. 761–765, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Kania, P. Blyszczuk, and U. Eriksson, “Mechanisms of cardiac fibrosis in inflammatory heart disease,” Trends in Cardiovascular Medicine, vol. 19, no. 8, pp. 247–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Heeschen, C. W. Hamm, J. Bruemmer, and M. L. Simoons, “Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis,” Journal of the American College of Cardiology, vol. 35, no. 6, pp. 1535–1542, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Kell, A. Haunstetter, T. J. Dengler, C. Zugck, W. Kübler, and M. Haass, “Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis,” European Heart Journal, vol. 23, no. 1, pp. 70–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. J. A. Jimenez and P. J. Mills, “Neuroimmune mechanisms of depression in heart failure,” Methods in Molecular Biology, vol. 934, pp. 165–182, 2012. View at Publisher · View at Google Scholar
  98. W. J. Kop, S. J. Synowski, and S. S. Gottlieb, “Depression in heart failure: biobehavioral mechanisms,” Heart Failure Clinics, vol. 7, no. 1, pp. 23–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. M. B. Howren, D. M. Lamkin, and J. Suls, “Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis,” Psychosomatic Medicine, vol. 71, no. 2, pp. 171–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. A. H. Miller, V. Maletic, and C. L. Raison, “Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression,” Biological Psychiatry, vol. 65, no. 9, pp. 732–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. W. J. Kop, E. A. Kuhl, E. Barasch, N. S. Jenny, S. S. Gottlieb, and J. S. Gottdiener, “Association between depressive symptoms and fibrosis markers: the cardiovascular health study,” Brain, Behavior, and Immunity, vol. 24, no. 2, pp. 229–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Vaccarino, B. D. Johnson, D. S. Sheps et al., “Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia. The national heart, lung, and blood institute-sponsored WISE study,” Journal of the American College of Cardiology, vol. 50, no. 21, pp. 2044–2050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. T. Katafuchi, T. Kondo, S. Take, and M. Yoshimura, “Brain cytokines and the 5-HT system during poly I:C-induced fatigue,” Annals of the New York Academy of Sciences, vol. 1088, pp. 230–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Katafuchi, T. Kondo, S. Take, and M. Yoshimura, “Enhanced expression of brain interferon-α and serotonin transporter in immunologically induced fatigue in rats,” European Journal of Neuroscience, vol. 22, no. 11, pp. 2817–2826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. B. Wirleitner, V. Rudzite, G. Neurauter et al., “Immune activation and degradation of tryptophan in coronary heart disease,” European Journal of Clinical Investigation, vol. 33, no. 7, pp. 550–554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. B. P. Skop and T. M. Brown, “Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors,” Psychosomatics, vol. 37, no. 1, pp. 12–16, 1996. View at Scopus
  107. K. Miyata, H. Shimokawa, T. Higo et al., “Sarpogrelate, a selective 5-HT(2A) serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model,” Journal of Cardiovascular Pharmacology, vol. 35, no. 2, pp. 294–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Verma, C. H. Wang, S. H. Li et al., “A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis,” Circulation, vol. 106, no. 8, pp. 913–919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. D. Fischer, S. Rossa, U. Landmesser et al., “Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death,” European Heart Journal, vol. 26, no. 1, pp. 65–69, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. S. D. Katz, K. Hryniewicz, I. Hriljac et al., “Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure,” Circulation, vol. 111, no. 3, pp. 310–314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. D. C. Cooper, M. S. Milic, J. R. Tafur et al., “Adverse impact of mood on flow-mediated dilation,” Psychosomatic Medicine, vol. 72, no. 2, pp. 122–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. L. M. Tomfohr, M. L. M. Murphy, G. E. Miller, and E. Puterman, “Multiwave associations between depressive symptoms and endothelial function in adolescent and young adult females,” Psychosomatic Medicine, vol. 73, no. 6, pp. 456–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Pizzi, L. Manzoli, S. Mancini, and G. M. Costa, “Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function,” European Heart Journal, vol. 29, no. 9, pp. 1110–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Sherwood, A. L. Hinderliter, L. L. Watkins, R. A. Waugh, and J. A. Blumenthal, “Impaired endothelial function in coronary heart disease patients with depressive symptomatology,” Journal of the American College of Cardiology, vol. 46, no. 4, pp. 656–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. C. Pizzi, S. Mancini, L. Angeloni, F. Fontana, L. Manzoli, and G. M. Costa, “Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease,” Clinical Pharmacology and Therapeutics, vol. 86, no. 5, pp. 527–532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Vikenes, M. Farstad, and J. E. Nordrehaug, “Serotonin is associated with coronary artery disease and cardiac events,” Circulation, vol. 100, no. 5, pp. 483–489, 1999. View at Scopus
  117. V. L. Serebruany, R. F. Suckow, T. B. Cooper et al., “Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression,” The American Journal of Psychiatry, vol. 162, no. 6, pp. 1165–1170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. V. L. Serebruany, P. A. Gurbel, and C. M. O'Connor, “Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors,” Pharmacological Research, vol. 43, no. 5, pp. 453–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. A. Schins, K. Hamulyák, S. Scharpé et al., “Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients,” Life Sciences, vol. 76, no. 6, pp. 637–650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. R. C. Arora and H. Y. Meltzer, “Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients,” Life Sciences, vol. 44, no. 11, pp. 725–734, 1989. View at Scopus
  121. P. D. Hrdina, D. Bakish, A. Ravindran, J. Chudzik, P. Cavazzoni, and Y. D. Lapierre, “Platelet serotonergic indices in major depression: up-regulation of 5-HT(2A) receptors unchanged by antidepressant treatment,” Psychiatry Research, vol. 66, no. 2-3, pp. 73–85, 1997. View at Publisher · View at Google Scholar · View at Scopus
  122. C. B. Nemeroff, D. L. Knight, J. Franks, W. E. Craighead, and K. R. R. Krishnan, “Further studies on platelet serotonin transporter binding in depression,” The American Journal of Psychiatry, vol. 151, no. 11, pp. 1623–1625, 1994. View at Scopus
  123. P. M. J. C. Kuijpers, K. Hamulyak, J. J. M. H. Strik, H. J. J. Wellens, and A. Honig, “β-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression,” Psychiatry Research, vol. 109, no. 2, pp. 207–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  124. V. L. Serebruany, A. H. Glassman, A. I. Malinin et al., “Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials,” Blood Coagulation and Fibrinolysis, vol. 14, no. 6, pp. 563–567, 2003. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Gehi, D. Musselman, C. Otte, E. B. Royster, S. Ali, and M. A. Whooley, “Depression and platelet activation in outpatients with stable coronary heart disease: findings from the heart and soul study,” Psychiatry Research, vol. 175, no. 3, pp. 200–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. I. S. Anand, L. D. Fisher, Y. T. Chiang et al., “Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-HeFT),” Circulation, vol. 107, no. 9, pp. 1278–1283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. J. N. Cohn, T. B. Levine, M. T. Olivari et al., “Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure,” The New England Journal of Medicine, vol. 311, no. 13, pp. 819–823, 1984. View at Scopus
  128. P. W. Gold, M. L. Wong, D. S. Goldstein et al., “Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 23, pp. 8303–8308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. M. P. Frenneaux, “Autonomic changes in patients with heart failure and in post-myocardial infarction patients,” Heart, vol. 90, no. 11, pp. 1248–1255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. M. T. La Rovere, G. D. Pinna, S. H. Hohnloser et al., “Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials,” Circulation, vol. 103, no. 16, pp. 2072–2077, 2001. View at Scopus
  131. F. Buccelletti, E. Gilardi, E. Scaini et al., “Heart rate variability and myocardial infarction: systematic literature review and metanalysis,” European Review for Medical and Pharmacological Sciences, vol. 13, no. 4, pp. 299–307, 2009. View at Scopus
  132. P. J. Schwartz, E. Vanoli, M. Stramba-Badiale, G. M. de Ferrari, G. E. Billman, and R. D. Foreman, “Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction,” Circulation, vol. 78, no. 4 I, pp. 969–979, 1988. View at Scopus
  133. A. H. Kemp, D. S. Quintana, M. A. Gray, K. L. Felmingham, K. Brown, and J. M. Gatt, “Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis,” Biological Psychiatry, vol. 67, no. 11, pp. 1067–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. A. H. Glassman, J. T. Bigger, M. Gaffney, and L. T. van Zyl, “Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement,” Archives of General Psychiatry, vol. 64, no. 9, pp. 1025–1031, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. T. K. Dao, N. A. Youssef, R. R. Gopaldas et al., “Autonomic cardiovascular dysregulation as a potential mechanism underlying depression and coronary artery bypass grafting surgery outcomes,” Journal of Cardiothoracic Surgery, vol. 5, no. 1, article 36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. K. Hashimoto, “Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions,” Psychiatry and Clinical Neurosciences, vol. 64, no. 4, pp. 341–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. E. Castrén and T. Rantamäki, “The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity,” Developmental Neurobiology, vol. 70, no. 5, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. M. L. Molendijk, B. A. Bus, P. Spinhoven et al., “Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment,” Molecular Psychiatry, vol. 16, no. 11, pp. 1088–1095, 2011. View at Publisher · View at Google Scholar
  139. K. Ohira, R. Takeuchi, H. Shoji, and T. Miyakawa, “Fluoxetine-iduced cortical adult neurogenesis,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  140. H. Kim, Q. Li, B. L. Hempstead, and J. A. Madri, “Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells,” The Journal of Biological Chemistry, vol. 279, no. 32, pp. 33538–33546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  141. S. Okada, M. Yokoyama, H. Toko et al., “Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1902–1909, 2012. View at Publisher · View at Google Scholar
  142. K. Hashimoto, “Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression,” Progress in Neurobiology, vol. 100, pp. 15–29, 2013. View at Publisher · View at Google Scholar
  143. V. Sabino, P. Cottone, S. L. Parylak, L. Steardo, and E. P. Zorrilla, “Sigma-1 receptor knockout mice display a depressive-like phenotype,” Behavioural Brain Research, vol. 198, no. 2, pp. 472–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. T. Maurice and T. P. Su, “The pharmacology of sigma-1 receptors,” Pharmacology and Therapeutics, vol. 124, no. 2, pp. 195–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. K. Ito, Y. Hirooka, R. Matsukawa, M. Nakano, and K. Sunagawa, “Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression,” Cardiovascular Research, vol. 93, no. 1, pp. 33–40, 2012. View at Publisher · View at Google Scholar
  146. H. Kunugi, H. Hori, N. Adachi, and T. Numakawa, “Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression,” Psychiatry and Clinical Neurosciences, vol. 64, no. 5, pp. 447–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. L. K. Bauer, M. A. Caro, S. R. Beach et al., “Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients,” The American Journal of Cardiology, vol. 109, no. 9, pp. 1266–1271, 2012. View at Publisher · View at Google Scholar
  148. M. A. Whooley, P. de Jonge, E. Vittinghoff et al., “Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease,” The Journal of the American Medical Association, vol. 300, no. 20, pp. 2379–2388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. H. T. May, X. Sheng, A. P. Catinella, B. D. Horne, J. F. Carlquist, and E. Joy, “Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression,” Journal of Psychosomatic Research, vol. 69, no. 2, pp. 169–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. E. Casey, J. W. Hughes, D. Waechter, R. Josephson, and J. Rosneck, “Depression predicts failure to complete phase-II cardiac rehabilitation,” Journal of Behavioral Medicine, vol. 31, no. 5, pp. 421–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. A. McGrady, R. McGinnis, D. Badenhop, M. Bentle, and M. Rajput, “Effects of depression and anxiety on adherence to cardiac rehabilitation,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 29, no. 6, pp. 358–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. J. C. Huffman, F. A. Smith, G. L. Fricchione, J. L. Januzzi, S. Nadelman, and W. F. Pirl, “Depression and failure of cholesterol lowering after acute myocardial infarction,” Primary Care Companion to the Journal of Clinical Psychiatry, vol. 12, no. 1, Article ID PCC.08m00766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. A. K. Gehi, S. Ali, B. Na, and M. A. Whooley, “Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study,” Archives of Internal Medicine, vol. 167, no. 16, pp. 1798–1803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. T. R. Wessel, C. B. Arant, M. B. Olson et al., “Relationship of physical fitness versus body mass index with coronary artery disease and cardiovascular events in women,” The Journal of the American Medical Association, vol. 292, no. 10, pp. 1179–1187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. J. C. Huffman, F. A. Smith, M. A. Blais, M. E. Beiser, J. L. Januzzi, and G. L. Fricchione, “Recognition and treatment of depression and anxiety in patients with acute myocardial infarction,” The American Journal of Cardiology, vol. 98, no. 3, pp. 319–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  156. R. C. Ziegelstein, S. Y. Kim, D. Kao et al., “Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening?” Psychosomatic Medicine, vol. 67, no. 3, pp. 393–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. J. H. Lichtman, J. T. Bigger Jr., J. A. Blumenthal et al., “Depression and coronary heart disease: recommendations for screening, referral, and treatment—a science advisory from the American heart association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes research,” Circulation, vol. 118, no. 17, pp. 1768–1775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  158. L. Elderon, K. G. Smolderen, B. Na, and M. A. Whooley, “Accuracy and prognostic value of American heart association: recommended depression screening in patients with coronary heart disease: data from the heart and soul study,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 5, pp. 533–540, 2011. View at Publisher · View at Google Scholar
  159. B. L. Rollman, B. H. Belnap, S. Mazumdar et al., “A positive 2-item patient health questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality,” Journal of Cardiac Failure, vol. 18, no. 3, pp. 238–245, 2012. View at Publisher · View at Google Scholar
  160. B. D. Thombs, R. C. Ziegelstein, and M. A. Whooley, “Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study,” Journal of General Internal Medicine, vol. 23, no. 12, pp. 2014–2017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  161. G. Sowden, C. A. Mastromauro, J. L. Januzzi, G. L. Fricchione, and J. C. Huffman, “Detection of depression in cardiac inpatients: feasibility and results of systematic screening,” The American Heart Journal, vol. 159, no. 5, pp. 780–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  162. K. G. Smolderen, D. M. Buchanan, A. A. Amin et al., “Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 3, pp. 283–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. R. C. Ziegelstein, B. D. Thombs, J. C. Coyne, and P. de Jonge, “Routine screening for depression in patients with coronary heart disease. Never mind,” Journal of the American College of Cardiology, vol. 54, no. 10, pp. 886–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. K. W. Davidson, N. Rieckmann, L. Clemow et al., “Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial,” Archives of Internal Medicine, vol. 170, no. 7, pp. 600–608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. J. C. Huffman, C. A. Mastromauro, G. Sowden, G. L. Fricchione, B. C. Healy, and J. L. Januzzi, “Impact of a depression care management program for hospitalized cardiac patients,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 2, pp. 198–205, 2011. View at Publisher · View at Google Scholar
  166. W. J. Katon, E. H. B. Lin, M. V. Korff et al., “Collaborative care for patients with depression and chronic illnesses,” The New England Journal of Medicine, vol. 363, no. 27, pp. 2611–2620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. B. L. Rollman, B. H. Belnap, M. S. LeMenager et al., “Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial,” The Journal of the American Medical Association, vol. 302, no. 19, pp. 2095–2103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. M. A. Whooley, “To screen or not to screen? Depression in patients with cardiovascular disease,” Journal of the American College of Cardiology, vol. 54, no. 10, pp. 891–893, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. A. H. Glassman, C. M. O'Connor, R. M. Califf et al., “Sertraline treatment of major depression in patients with acute MI or unstable angina,” The Journal of the American Medical Association, vol. 288, no. 6, pp. 701–709, 2002. View at Scopus
  170. C. M. O'Connor, W. Jiang, M. Kuchibhatla et al., “Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial,” Journal of the American College of Cardiology, vol. 56, no. 9, pp. 692–699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  171. L. F. Berkman, J. Blumenthal, M. Burg et al., “Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial,” The Journal of the American Medical Association, vol. 289, no. 23, pp. 3106–3116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  172. K. E. Freedland, J. A. Skala, R. M. Carney et al., “Treatment of depression after coronary artery bypass surgery a randomized controlled trial,” Archives of General Psychiatry, vol. 66, no. 4, pp. 387–396, 2009. View at Publisher · View at Google Scholar · View at Scopus